ArticleFrontiers in immunology2024

Tumor microenvironment-modulating oncolytic adenovirus combined with GSK-3β inhibitor enhances antitumor immune response against bladder cancer.

A-Rum Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.